WASHINGTON - Evolent Health, Inc. (NYSE: EVH), a health outcomes company currently trading near its 52-week low at $10.21, today announced the appointment of Richard "Rick" Jelinek as its new Chair of ...
WASHINGTON, Feb. 4, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a company focused on achieving better health outcomes for people with complex conditions, today announced ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Evolent Health (EVH – Research Report) and Staar Surgical ...
Chicago Partners Investment Group LLC boosted its position in shares of Evolent Health, Inc. (NYSE:EVH – Free Report) by 50.0 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results